Risk of hypoglycemia following intensification of metformin treatment with insulin versus sulfonylurea.

Abstract

Hypoglycemia remains a common life-threatening event associated with diabetes treatment. We compared the risk of first or recurrent hypoglycemia event among metformin initiators who intensified treatment with insulin versus sulfonylurea.